R. Miller

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.

S. Shah, D. Bowtell, S. Nik-Zainal, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Clear cell ovarian cancer (CCOC): Predicting risk of relapse (ROR).

J. Ledermann, R. Kristeleit, M. Devlin, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Bevacizumab Enables Surgery in Previously Inoperable Patients with Advanced Low-Grade Serous Ovarian Cancer

M. Lockley, A. Hameeduddin, R. Miller, 2020 .

Olaparib plus paclitaxel sensitivity in biomarker subgroups of gastric cancer.

J. Barrett, D. Hodgson, S. Im, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.